Pearls: Myasthenia

ABSTRACT

Myasthenia gravis is typically an acquired autoimmune disorder in which antibodies are directed at structural components of the neuromuscular junction, most commonly the nicotinic acetylcholine receptor. The clinical manifestations of skeletal muscle weakness are broad. Patients most often report fatigable muscle weakness. The eyelid levators and extraocular muscles are most commonly affected, resulting in symptoms of ptosis and diplopia. Symptoms may be confined to the eyes (ocular myasthenia) or reflect bulbar, limb, or respiratory muscle weakness (generalized myasthenia). The diagnosis is based on a characteristic history and the finding of fatigable muscle weakness on examination, and may be supported by diagnostic tests such as finding elevated titers of acetylcholine receptor or muscle-specific receptor tyrosine kinase (MuSK) antibodies, a positive Tensilon test, a decremental response on slow repetitive nerve stimulation, and abnormal jitter on single fiber electromyography. This article presents a series of pearls to aid in the clinical and laboratory diagnosis of myasthenia gravis, emphasizing key historical features, common and characteristic findings on examination, and potential pitfalls in the use of ancillary diagnostic studies.

KEYWORDS

Acquired autoimmune myasthenia gravis - clinical examination - diagnostic tests

REFERENCES

• 1 Grob D, Arsura E L, Brunner N G, Namba T. The course of myasthenia gravis and therapies affecting outcome.  Ann N Y Acad Sci. 1987;  505 472-499
• 2 Evoli A, Tonali P, Bartoccioni E, Lo Monaco M. Ocular myasthenia: diagnostic and therapeutic problems.  Acta Neurol Scand. 1988;  77(1) 31-35
• 3 Rush J A, Shafrin F. Ocular myasthenia presenting as superior oblique weakness.  J Clin Neuroophthalmol. 1982;  2(2) 125-127
• 4 Spoor T C, Shippman S. Myasthenia gravis presenting as an isolated inferior rectus paresis.  Ophthalmology. 1979;  86(12) 2158-2160
• 5 Glaser J S. Myasthenic psuedo-internuclear ophthalmoplegia.  Arch Ophthalmol. 1966;  75(3) 363-366
• 6 Davis T L, Lavin P J. Pseudo one-and-a-half syndrome with ocular myasthenia.  Neurology. 1989;  39(11) 1553
• 7 Glaser J, Siatkowski R M. Infranuclear disorders of eye movement. In: Glaser J Neuroophthalmology. 3rd ed. Philadelphia, PA; Lippincott Williams & Wilkins 1999: 405-409
• 8 Leigh R, Zee D. The Neurology of Eye Movements. 4th ed. New York; Oxford University Press 2006: 439-444
• 9 Oosterhuis H. Myasthenia Gravis. Groningen, The Netherlands; Groningen Neurological Press 1997
• 10 Werner P, Kiechl S, Löscher W, Poewe W, Willeit J. Distal myasthenia gravis frequency and clinical course in a large prospective series.  Acta Neurol Scand. 2003;  108(3) 209-211
• 11 O’Suilleabhain P, Low P A, Lennon V A. Autonomic dysfunction in the Lambert-Eaton myasthenic syndrome: serologic and clinical correlates.  Neurology. 1998;  50(1) 88-93
• 12 Evoli A, Tonali P A, Padua L et al.. Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis.  Brain. 2003;  126(Pt 10) 2304-2311
• 13 Sanders D B, El-Salem K, Massey J M, McConville J, Vincent A. Clinical aspects of MuSK antibody positive seronegative MG.  Neurology. 2003;  60(12) 1978-1980
• 14 Benatar M. A systematic review of diagnostic studies in myasthenia gravis.  Neuromuscul Disord. 2006;  16(7) 459-467
• 15 Howard Jr F M, Lennon V A, Finley J, Matsumoto J, Elveback L R. Clinical correlations of antibodies that bind, block, or modulate human acetylcholine receptors in myasthenia gravis.  Ann N Y Acad Sci. 1987;  505 526-538
• 16 Chan J W, Orrison W W. Ocular myasthenia: a rare presentation with MuSK antibody and bilateral extraocular muscle atrophy.  Br J Ophthalmol. 2007;  91(6) 842-843
• 17 Benatar M, Hammad M, Doss-Riney H. Concentric-needle single-fiber electromyography for the diagnosis of myasthenia gravis.  Muscle Nerve. 2006;  34(2) 163-168
• 18 Costa J, Evangelista T, Conceição I, de Carvalho M. Repetitive nerve stimulation in myasthenia gravis—relative sensitivity of different muscles.  Clin Neurophysiol. 2004;  115(12) 2776-2782